Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: OraSure Technologies, Inc.

Market Cap 308M 269M 247M 233M 435M 29.03B 439M 2.95B 1.14B 14.29B 1.16B 1.13B 49.65B P/E 2026 *
-4.26x
P/E 2027 * -5.45x
Enterprise Value 308M 269M 247M 233M 435M 29.03B 439M 2.95B 1.14B 14.29B 1.16B 1.13B 49.65B EV / Sales 2026 *
2.57x
EV / Sales 2027 * 2.41x
Free-Float
93.62%
Yield 2026 *
-
Yield 2027 * -
1 day-4.92%
1 week+5.46%
Current month-1.16%
1 month+41.67%
3 months+42.62%
6 months+72.76%
Current year+75.62%
1 week 4.01
Extreme 4.01
4.58
1 month 2.96
Extreme 2.955
4.58
Current year 2.33
Extreme 2.33
4.58
1 year 2.08
Extreme 2.08
4.58
3 years 2.08
Extreme 2.08
8.45
5 years 2.08
Extreme 2.08
13.57
10 years 2.08
Extreme 2.08
23.01
Manager TitleAgeSince
Chief Executive Officer 52 03/06/2022
Director of Finance/CFO 54 07/08/2022
Chief Tech/Sci/R&D Officer - 30/11/2024
Director TitleAgeSince
Director/Board Member 59 31/05/2020
Director/Board Member 66 07/11/2021
Director/Board Member 52 03/06/2022
Date Insider Type Main position Quantity % Market Cap.
06-02Free

Director

46,106 0.0670%
06-02Free

Director

46,106 0.0670%
06-02Free

Chairman

46,106 0.0670%
Change 5-day change 1-year change 3-year change Capi.($)
-4.92%+5.46%+51.25%-22.30% 308M
-0.10%-0.85%-33.16%-16.75% 154B
+1.54%-1.13%-7.93%-11.00% 100B
+3.24%+10.91%+72.09%+62.85% 57.66B
-1.90%-3.35%-7.29%+48.53% 53.91B
+1.67%-2.58%-15.28%-44.33% 39.02B
-1.32%-1.64% - - 30.8B
+1.74%-3.08%-11.44%-44.30% 27.49B
+1.35%-0.90%+50.39%-9.42% 22.86B
+0.58%-2.14%-12.73%-2.31% 20.68B
Average +0.19%+0.22%+9.55%-4.34% 50.72B
Weighted average by Cap. +0.66%-0.60%-4.51%-1.39%

Financials

2026 *2027 *
Net sales 120M 104M 96.25M 90.64M 169M 11.29B 171M 1.15B 444M 5.56B 449M 440M 19.31B 128M 112M 103M 96.82M 181M 12.06B 182M 1.22B 474M 5.94B 480M 470M 20.63B
Net income -73.68M -64.29M -59.25M -55.8M -104M -6.95B -105M -705M -273M -3.42B -277M -271M -11.89B -57.65M -50.3M -46.35M -43.66M -81.45M -5.44B -82.19M -552M -214M -2.68B -216M -212M -9.3B
Net Debt - -
Logo OraSure Technologies, Inc.
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its products and services include OraQuick ADVANCE Rapid HIV 1/2 Antibody Test, OraQuick HIV Self-Test, Diagnostics Direct Syphilis Health Check, OraQuick Ebola Rapid Antigen Test, InteliSwab COVID-19 Rapid Test Pro, and SickleSCAN Test, among others. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers.
Employees
500
Date Price Change Volume
18/06/26 4.240 $ -5.15% 1,319,549
17/06/26 4.470 $ +3.47% 744,286
16/06/26 4.320 $ +3.60% 657,838
15/06/26 4.170 $ -0.24% 523,246
12/06/26 4.180 $ -0.24% 506,169
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
4.470USD
Average target price
4.750USD
Spread / Average Target
+6.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OSUR Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!